Collaborators GBDDF. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105–25.

Article  Google Scholar 

Wimo A, Seeher K, Cataldi R, Cyhlarova E, Dielemann JL, Frisell O, et al. The worldwide costs of dementia in 2019. Alzheimers Dement. 2023;19(7):2865–73.

Article  PubMed  Google Scholar 

Hendriks S, Ranson JM, Peetoom K, Lourida I, Tai XY, de Vugt M, et al. Risk factors for young-onset dementia in the UK Biobank. JAMA Neurol. 2024;81(2):134–42.

Article  PubMed  Google Scholar 

Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413–46.

Article  PubMed  PubMed Central  Google Scholar 

Deckers K, van Boxtel MP, Schiepers OJ, de Vugt M, Munoz Sanchez JL, Anstey KJ, et al. Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry. 2015;30(3):234–46.

Article  PubMed  Google Scholar 

North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res. 2012;110(8):1097–108.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao K, Chen P, Alexander-Bloch A, Wei Y, Dyrba M, Yang F, et al. A neuroimaging biomarker for Individual Brain-Related Abnormalities In Neurodegeneration (IBRAIN): a cross-sectional study. EClinicalMedicine. 2023;65:102276.

Article  PubMed  PubMed Central  Google Scholar 

Tun X, Wang EJ, Gao Z, Lundberg K, Xu R, Hu D. Integrin beta3-mediated cell senescence associates with gut inflammation and intestinal degeneration in models of Alzheimer’s disease. Int J Mol Sci. 2023;24(6).

Rommer PS, Bsteh G, Zrzavy T, Hoeftberger R, Berger T. Immunosenescence in neurological diseases-is there enough evidence? Biomedicines. 2022;10(11).

Yang T, Xiao Y, Cheng Y, Huang J, Wei Q, Li C, et al. Epigenetic clocks in neurodegenerative diseases: a systematic review. J Neurol Neurosurg Psychiatry. 2023;94(12):1064–70.

Article  PubMed  Google Scholar 

Liu Z, Kuo PL, Horvath S, Crimmins E, Ferrucci L, Levine M. A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study. PLoS Med. 2018;15(12):e1002718.

Article  PubMed  PubMed Central  Google Scholar 

Gao X, Geng T, Jiang M, Huang N, Zheng Y, Belsky DW, et al. Accelerated biological aging and risk of depression and anxiety: evidence from 424,299 UK Biobank participants. Nat Commun. 2023;14(1):2277.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou A, Wu Z, Zaw Phyo AZ, Torres D, Vishwanath S, Ryan J. Epigenetic aging as a biomarker of dementia and related outcomes: a systematic review. Epigenomics. 2022;14(18):1125–38.

Article  CAS  PubMed  Google Scholar 

Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261(5123):921–3.

Article  CAS  PubMed  Google Scholar 

Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673–734.

Article  PubMed  Google Scholar 

Ebenau JL, van der Lee SJ, Hulsman M, Tesi N, Jansen IE, Verberk IMW, et al. Risk of dementia in APOE ε4 carriers is mitigated by a polygenic risk score. Alzheimers Dement (Amst). 2021;13(1):e12229.

Article  PubMed  Google Scholar 

Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLos Med. 2015;12(3):10.

Article  Google Scholar 

Levine ME, Lu AT, Quach A, Chen BH, Assimes TL, Bandinelli S, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging-US. 2018;10(4):573–91.

Article  Google Scholar 

Liu Z, Kuo P-L, Horvath S, Crimmins E, Ferrucci L, Levine M. A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: a cohort study. PLos Med. 2018;15(12):e1002718.

Article  PubMed  PubMed Central  Google Scholar 

Rasmussen KL, Tybjærg-Hansen A, Nordestgaard BG, Frikke-Schmidt R. APOE and dementia - resequencing and genotyping in 105,597 individuals. Alzheimers Dement. 2020;16(12):1624–37.

Article  PubMed  Google Scholar 

Ma H, Li X, Zhou T, Wang MY, Heianza Y, Qi L. Long-term exposure to low-level air pollution, genetic susceptibility and risk of dementia. Int J Epidemiol. 2023;52(3):738–48.

Article  PubMed  Google Scholar 

Littlejohns TJ, Collister JA, Liu XN, Clifton L, Tapela NM, Hunter DJ. Hypertension, a dementia polygenic risk score, APOE genotype, and incident dementia. Alzheimers Dement. 2023;19(2):467–76.

Article  CAS  PubMed  Google Scholar 

Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genet. 2019;51(3):414-+.

Article  CAS  PubMed  Google Scholar 

Ebenau JL, van der Lee SJ, Hulsman M, Tesi N, Jansen IE, Verberk IMW, et al. Risk of dementia in APOE epsilon4 carriers is mitigated by a polygenic risk score. Alzheimer’s & dementia (Amsterdam, Netherlands). 2021;13(1):e12229.

Google Scholar 

Wilkinson T, Ly A, Schnier C, Rannikmae K, Bush K, Brayne C, et al. Identifying dementia cases with routinely collected health data: A systematic review. Alzheimers Dement. 2018;14(8):1038–51.

Article  PubMed  Google Scholar 

van der Flier WM, Pijnenburg YAL, Fox NC, Scheltens P. Early-onset versus late-onset Alzheimer’s disease: the case of the missing <i>APOE</i> ε4 allele. Lancet Neurol. 2011;10(3):280–8.

Article  PubMed  Google Scholar 

Seath P, Macedo-Orrego LE, Velayudhan L. Clinical characteristics of early-onset versus late-onset Alzheimer’s disease: a systematic review and meta-analysis. Int Psychogeriatr. 2023:17.

Sabbagh MN, Perez A, Holland TM, Boustani M, Peabody SR, Yaffe K, et al. Primary prevention recommendations to reduce the risk of cognitive decline. Alzheimers Dement. 2022;18(8):1569–79.

Article  PubMed  Google Scholar 

WHO Guidelines Approved by the Guidelines Review Committee. Risk reduction of cognitive decline and dementia: WHO Guidelines. Geneva: World Health Organization. © World Health Organization 2019.; 2019.

Lourida I, Hannon E, Littlejohns TJ, Langa KM, Hyppönen E, Kuzma E, et al. Association of lifestyle and genetic risk with incidence of dementia. JAMA-J Am Med Assoc. 2019;322(5):430–7.

Article  Google Scholar 

Shen C, Rolls ET, Cheng W, Kang JJ, Dong GY, Xie C, et al. Associations of social isolation and loneliness with later dementia. Neurology. 2022;99(2):E164–75.

Article  PubMed  Google Scholar 

Ma LZ, Zhang YR, Li YZ, Ou YN, Yang L, Chen SD, et al. Cataract, cataract surgery, and risk of incident dementia: a prospective cohort study of 300,823 participants. Biol Psychiatry. 2023;93(1):810–9.

Article  PubMed  Google Scholar 

Gentreau M, Rukh G, Miguet M, Clemensson LE, Alsehli AM, Titova OE, et al. The effects of statins on cognitive performance are mediated by low-density lipoprotein, C-reactive protein, and blood glucose concentrations. J Gerontol Ser A-Biol Sci Med Sci. 2023;78(11):1964–72.

CAS  Google Scholar 

Kung CSJ, Pudney SE, Shields MA. Economic gradients in loneliness, social isolation and social support: evidence from the UK Biobank. Soc Sci Med. 2022;306:14.

Article  Google Scholar 

Wang JL, Gao YY, Lin YJ, Sun XM, Ye SZ, Shi Y, et al. Interactive effects of air pollutants and temperature on incidence of dementia: a prospective cohort study. Environ Res Lett. 2023;18(7):15.

Article  Google Scholar 

Camargo KR Jr, Ortega F, Coeli CM. Modern epidemiology and its discontents. Rev Saude Publica. 2013;47(5):984–91.

Article  PubMed  Google Scholar 

Jylhava J, Pedersen NL, Hagg S. Biological age predictors EBioMedicine. 2017;21:29–36.

Article  PubMed  Google Scholar 

Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26(11):2389–430.

Article  CAS  PubMed